The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-cell immune mapping of adenoid cystic carcinoma (ACC) reveals potential therapeutic targets for the aggressive solid subtype.
 
Luana Guimaraes de Sousa
No Relationships to Disclose
 
Felippe Lazar Neto
No Relationships to Disclose
 
Daniel James McGrail
No Relationships to Disclose
 
Kaiyi Li
No Relationships to Disclose
 
Mario L. Marques-Piubelli
No Relationships to Disclose
 
Sammy Ferri Borgogno
No Relationships to Disclose
 
Hui Dai
No Relationships to Disclose
 
Yoshitsugu Mitani
No Relationships to Disclose
 
Shiaw-Yih Lin
No Relationships to Disclose
 
Adel K. El-Naggar
No Relationships to Disclose
 
Diana Bell
No Relationships to Disclose
 
Jared Burks
No Relationships to Disclose
 
Renata Ferrarotto
Consulting or Advisory Role - Ayala Pharmaceuticals; Bicara Therapeutics; Elevar Therapeutics; G1 Therapeutics; Guidepoint Global; Intellisphere; Merck Serono; Prelude Therapeutics; Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); Ayala Pharmaceuticals (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst); Prelude Therapeutics (Inst)